Skip to main navigation Skip to search Skip to main content

Monitoring Adverse Experiences in Clinical Drug Development

Research output: Contribution to book or proceedingConference articlepeer-review

Abstract

This conference abstract was published in the Proceedings of the BIO-IT World Expo Preconference Workshop 2.

Original languageAmerican English
Title of host publicationProceedings of the BIO-IT World Expo Preconference Workshop 2.
StatePublished - Apr 27 2009

Publication series

NameProceedings of the BIO-IT World Expo Preconference Workshop 2

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Disciplines

  • Biostatistics
  • Community Health
  • Public Health

Keywords

  • Adverse experiences
  • Clinical drug development
  • Monitoring

Fingerprint

Dive into the research topics of 'Monitoring Adverse Experiences in Clinical Drug Development'. Together they form a unique fingerprint.

Cite this